HCW Biologics Inc. (HCWB) is a publicly traded company in the Unknown sector. Across all available filings, 10 corporate insiders have executed 100 transactions totaling $8.1M, demonstrating a bullish sentiment with $8.1M in net insider flow. The most recent transaction on Feb 20, 2024 involved a transaction of 760,714 shares valued at $1.1M.
No significant insider buying has been recorded for HCWB in the recent period.
No significant insider selling has been recorded for HCWB in the recent period.
Based on recent SEC filings, insider sentiment for HCWB is bullish with an Insider Alignment Score of 100/100 and a net flow of $8.1M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
Insider trading at HCW Biologics Inc. (HCWB) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 10 insiders are actively trading HCWB stock, having executed 100 transactions in the past 90 days. The most active insider is Hing C. Wong (Executive), who has made 23 transactions totaling $6.3M.
Get notified when executives and directors at HCWB file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 20, 2024 | Byam Rebecca | Executive | Award | 760,714 | $1.40 | $1.1M | Large |
| Feb 20, 2024 | Flowers Lee | Executive | Award | 71,429 | $1.40 | $100.0K | |
| Feb 20, 2024 | T. Garrett Scott | Executive | Award | 142,858 | $1.40 | $200.0K | |
| Feb 20, 2024 | M. Giles Lisa | Executive | Award | 35,715 | $1.40 | $50.0K | |
| Feb 20, 2024 | S. Greene Rick | Executive | Award | 35,714 | $1.40 | $50.0K | |
| Feb 20, 2024 | C. Wong Hing | Executive | Award | 739,288 | $1.40 | $1.0M | Large |
| Dec 11, 2023 | Rhode Peter | Executive | Option Exercise | 14,000 | $0.14 | $2.0K | |
| Dec 8, 2023 | Flowers Lee | Executive | Option Exercise | 7,501 | $0.14 | $1.1K | |
| Nov 17, 2023 | Rhode Peter | Executive | Option Exercise | 15,000 | $0.14 | $2.1K | |
| Oct 19, 2023 | Byam Rebecca | Executive | Option Exercise | 47,249 | $0.14 | $6.6K | |
| Sep 14, 2023 | M. Winer Gary | Executive | Purchase | 162 | $2.08 | $337 | |
| Sep 14, 2023 | M. Winer Gary | Executive | Purchase | 879 | $2.05 | $1.8K | |
| Sep 14, 2023 | C. Wong Hing | Executive | Purchase | 1,800 | $2.08 | $3.7K | |
| Sep 13, 2023 | Byam Rebecca | Executive | Purchase | 5,000 | $2.10 | $10.5K | |
| Sep 13, 2023 | M. Winer Gary | Executive | Purchase | 46 | $2.00 | $92 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Purchase(P) | 76 | $8.1M | 76.2% |
Award(A) | 6 | $2.5M | 23.6% |
Exercise(M) | 12 | $24.1K | 0.2% |
Other(J) | 1 | $0 | 0.0% |
Conversion(C) | 5 | $0 | 0.0% |
Insiders at HCW Biologics Inc. are accumulating shares at an accelerated pace. With 10 insiders making 100 transactions totaling $8.1M in purchases versus $0 in sales, the net buying activity of $8.1M signals strong executive confidence. Hing C. Wong (Executive) leads the buying activity with $6.3M in transactions across all time.